Several anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the national list of essential medicines, with the government saying this......
Pharmaceutical major Wockhardt Ltd on Saturday claimed it has developed a form of long-lasting insulin called Glargin and plans to launch it in India by 2006."Glargin would have the ability to help......
'We've got a huge track record and success in bringing several biosimilars to the market.' IMAGE: Biocon Biologics, Biocon Park, Bengaluru. Photograph: Kind courtesy Biocon Biologics/Facebook......
As many as 34 new drugs were added to and 26 dropped from an updated list of essential medicines on Tuesday, with the government saying this will reduce “patients’ out-of-pocket......
'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo The market share that Biocon......
'The obvious opportunity is biosimilars, which are simpler but more expensive,' says Kiran Mazumdar-Shaw, founder of Biocon. Shorn of jargon, biosimilars are biological products that are highly......
Benchmark indices ended lower by over 1%, amid weakness in Asian peers, with financials shares contributing the most to the decline. Depreciating rupee and rise in crude oil prices further......